0.0950
-0.0732
(-43.52%)
As of January 24 at 3:00:00 PM EST. Market Open.
Breakdown
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Total Assets
7,449,912.0000
7,920,855.0000
8,044,758.0000
8,154,080.0000
Total Liabilities Net Minority Interest
3,762,000.0000
4,316,141.0000
4,131,402.0000
4,397,249.0000
Total Equity Gross Minority Interest
3,687,912.0000
3,604,714.0000
3,913,356.0000
3,756,831.0000
Total Capitalization
4,609,924.0000
4,485,673.0000
6,301,535.0000
6,555,465.0000
Common Stock Equity
3,687,912.0000
3,604,714.0000
3,913,356.0000
3,756,831.0000
Capital Lease Obligations
31,693.0000
28,071.0000
33,466.0000
15,323.0000
Net Tangible Assets
1,110,824.0000
972,234.0000
1,225,493.0000
1,439,646.0000
Working Capital
496,740.0000
-733,750.0000
1,057,182.0000
2,615,872.0000
Invested Capital
5,559,436.0000
6,399,583.0000
6,534,587.0000
6,711,019.0000
Tangible Book Value
1,110,824.0000
972,234.0000
1,225,493.0000
1,439,646.0000
Total Debt
1,903,217.0000
2,822,940.0000
2,654,697.0000
2,969,511.0000
Net Debt
835,202.0000
2,116,300.0000
1,820,284.0000
645,736.0000
Share Issued
2,161,366.3050
1,935,036.8050
1,935,036.8050
1,917,720.7470
Ordinary Shares Number
2,141,766.3050
1,915,436.8050
1,915,436.8050
1,911,576.7470
Treasury Shares Number
19,600.0000
19,600.0000
19,600.0000
6,144.0000
12/31/2020 - 9/25/2019
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
INTS Intensity Therapeutics, Inc.
2.4613
+1.71%
LIPO Lipella Pharmaceuticals Inc.
2.7400
-2.49%
KTTA Pasithea Therapeutics Corp.
2.5200
+2.86%
GRTX Galera Therapeutics, Inc.
0.0480
+6.67%
ITOS iTeos Therapeutics, Inc.
7.69
+0.65%
LXEO Lexeo Therapeutics, Inc.
5.84
+4.66%
KRON Kronos Bio, Inc.
1.0400
0.00%
LYEL Lyell Immunopharma, Inc.
0.6383
+5.50%
IPSC Century Therapeutics, Inc.
0.8913
-0.96%
LYRA Lyra Therapeutics, Inc.
0.1955
+4.21%